Timothée Olivier, MD· @Timothee_MD · X·· 1 day agoScore70
Body
Nice to see the MASTERPLAN study presented #ESMO26 and published in @TheLancetOncol !
Congrats to the authors!
Our new paper :
"A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials"
with @free_radical28 is out in EJC, open access :
https://www.sciencedirect.com/science/article/pii/S0959804926015728
Food for thoughts for ongoing and future trials in that space!👇
365 views · 4 likes · 3 reposts · 0 replies
Conference abstracts
3136ROmatched by Rapid oral 1: Gastrointestinal tumour, upper digestive
Randomised phase II study of mFOLFIRINOX ± SBRT in patients with high risk, borderline resectable or locally advanced pancreatic cancer: Results of the AGITG MASTERPLAN trial
https://esmocongress.esmo.orgSource: Timothée Olivier, MD · x.com